Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study. [electronic resource]
Producer: 20150915Description: 57-68 p. digitalISSN:- 1178-2005
- Adult
- Aged
- Asian People
- Bronchodilator Agents -- administration & dosage
- China -- epidemiology
- Double-Blind Method
- Drug Administration Schedule
- Dyspnea -- diagnosis
- Female
- Forced Expiratory Volume
- Glycopyrrolate -- administration & dosage
- Health Status
- Humans
- India -- epidemiology
- Lung -- drug effects
- Male
- Middle Aged
- Muscarinic Antagonists -- administration & dosage
- Philippines -- epidemiology
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Recovery of Function
- Republic of Korea -- epidemiology
- Severity of Illness Index
- Spirometry
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
- Vital Capacity
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.